Standard Biotools (LAB) Total Current Liabilities (2016 - 2025)
Standard Biotools (LAB) has disclosed Total Current Liabilities for 16 consecutive years, with $108.3 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities rose 64.36% to $108.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108.3 million through Dec 2025, up 64.36% year-over-year, with the annual reading at $108.3 million for FY2025, 64.36% up from the prior year.
- Total Current Liabilities for Q4 2025 was $108.3 million at Standard Biotools, roughly flat from $108.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $123.8 million in Q2 2024, with the low at $42.8 million in Q2 2022.
- Average Total Current Liabilities over 5 years is $71.8 million, with a median of $53.2 million recorded in 2021.
- The sharpest move saw Total Current Liabilities skyrocketed 177.6% in 2024, then crashed 53.74% in 2025.
- Over 5 years, Total Current Liabilities stood at $49.6 million in 2021, then dropped by 12.36% to $43.4 million in 2022, then soared by 151.66% to $109.3 million in 2023, then tumbled by 39.73% to $65.9 million in 2024, then surged by 64.36% to $108.3 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $108.3 million, $108.0 million, and $98.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.